Polmon

Active Ingredient(s): Dexchlorpheniramine Maleate
FDA Approved: * July 16, 2018
Pharm Company: * CAPELLON PHARMS LLC
Category: Allergies, Cough & Cold

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Polmon Overview

Dexchlorpheniramine (trade name Polaramine) is an antihistamine with anticholinergic properties used to treat allergic conditions such as hay fever or urticaria.[1][2] It is the pharmacologically active dextrorotatory isomer of chlorpheniramine. It was patented in 1962 and came into medical use in 1959.[3] Pharmacology Dexchlorpheniramine is an antihistamine, or an antagonist of the histamine H1 receptor. A study found that dexchlorpheniramin...

Read more Polmon Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Dexchlorpheniramine

Recent Polmon Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Dexchlorpheniramine Maleate
  • Syrup: 2mg/5ml
  • Tablet: 2mg
  • Tablet, Extended Release: 2mg, 4mg, 6mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Polmon: (1 result)

Sorted by National Drug Code
  • 64543-600 Polmon 2 mg/5ml Oral Solution by Capellon Pharmaceuticals, LLC

Other drugs which contain Dexchlorpheniramine Maleate or a similar ingredient: (3 results)